IN SILICO DOCKING STUDY OF HERBAL COMPOSITION AND DEVELOPMENT OF MOUTH DISSOLVING TABLETS FOR COMMON RESPIRATORY DISEASES THEREOF-Reference-Cited by-同舟云学术

IN SILICO DOCKING STUDY OF HERBAL COMPOSITION AND DEVELOPMENT OF MOUTH DISSOLVING TABLETS FOR COMMON RESPIRATORY DISEASES THEREOF

Published:2024-07-15 Issue: Volume: Page:59-64
ISSN:0975-7066
Container-title:International Journal of Current Pharmaceutical Research
language:
Short-container-title:Int J Curr Pharm Sci

Author:

CHANDWANI ANKITA^ORCID,MODI KARUNA,SHAH KAUSHIK^ORCID,SHAH MAMTA^ORCID

Abstract

Objective: The present study aims to develop a novel mouth dissolving tablets containing a combination of herbal extracts and a bioactive constituent and evaluating it for activity against common respiratory diseases (in silico studies). Methods: Docking study was done to provide a scientific foundation, keeping the traditional knowledge as a base. Four trial batches were developed. The final batch was then formulated and various pre and post-compression and assays were performed to evaluate the formation of good quality of product. The final batch was prepared by the method of direct compression and taken for accelerated stability studies. Results: The final batch containing 10 % active ingredients, 7.5 % super-disintegrant and 47 % diluent was found to be stable, easily producible and economic. Conclusion: This research work grasps possibilities for researchers in the development and evaluation of mouth-dissolving tablets with significant bioactive potential against common respiratory diseases.

Publisher

Innovare Academic Sciences Pvt Ltd

Reference42 articles.

1. Respiratory diseases of adults. In: Speizer FE, Horton S, Batt J, Slutsky AS, Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P. editors. Disease control priorities in developing countries. 2nd ed. Washington, (DC): International Bank for Reconstruction and Development/the World Bank; 2006. p. 1128-59.

2. European Respiratory Society. The global impact of respiratory disease. 2nd ed. Forum of International Respiratory Societies; 2017. p. 7-24.

3. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1459-544. doi: 10.1016/S0140-6736(16)31012-1, PMID 27733281.

4. Bousquet J, Kaltaev N. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. Geneva: World Health Organization; 2007. p. 146.

5. Burney PG, Patel J, Newson R, Minelli C, Naghavi M. Global and regional trends in COPD mortality, 1990-2010. Eur Respir J. 2015;45(5):1239-47. doi: 10.1183/09031936.00142414, PMID 25837037.